Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
NCT02169648
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Macular Edema
Branch Retinal Vein Occlusion
Central Retinal Vein Occlusion
Interventions
DRUG:
ranibizumab
Sponsor
Tokyo Medical University